Alar Pharmaceuticals Inc. (TPEX:6785)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
121.00
+1.50 (1.26%)
Jun 18, 2026, 1:30 PM CST
Market Cap8.08B -13.6%
Revenue (ttm)3.00M -48.4%
Net Income-112.77M
EPS-1.69
Shares Out 66.80M
PE Ration/a
Forward PEn/a
Dividend0.10 (0.08%)
Ex-Dividend DateJun 10, 2025
Volume94,746
Open120.00
Previous Close119.50
Day's Range119.00 - 125.50
52-Week Range111.00 - 317.00
Beta0.07
AnalystsBuy
Price Target290.00 (+139.67%)
Earnings DateAug 7, 2026

About Alar Pharmaceuticals

Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson’s disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan. [Read more]

Sector Healthcare
Founded 2016
Employees 32
Stock Exchange Taipei Exchange
Ticker Symbol 6785
Full Company Profile

Financial Performance

Financial Statements